在患有神经系统疾病的患者中使用肉毒素:美国的索赔数据库分析
David M Simpson1, Jonathan Bouchard2, Simon Page3
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
PM & R : the journal of injury, function, and rehabilitation
|March 12, 2026
概括
许多患者在仅经过一到两次治疗后就停止了肉毒素 (BoNT) 治疗,这凸显了了解治疗持续性的必要性. 进一步的研究对于优化患者护理和确定BoNT停止原因至关重要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 有限的现实世界的数据存在于长期的肉毒素 (BoNT) 治疗持久性.
- 了解治疗模式对于优化患者护理至关重要.
研究的目的:
- 为了评估治疗模式和长期持久性,在临床实践中在2年的时间内使用肉毒素 (BoNT) 治疗.
- 分析各种适应症的BoNT治疗中止率.
主要方法:
- 美国索赔数据库 (Merative MarketScan) 的回顾性纵向分析.
- 包括2016年10月至2019年10月期间索引BoNT索赔的患者,至少2年的随访时间.
- 使用120天前标准评估治疗频率,治疗间的时间和持续性.
主要成果:
- 很大一部分患者 (31.1%) 在两年内只接受了一次BoNT注射周期.
- 平均治疗周期在不同的适应症中从2.1到4.7不等.
- 治疗之间的时间有所不同,第80个百分点的时间从105天到319天,这取决于患者队列.
结论:
- 相当数量的患者在初始循环后停止了肉毒素 (BoNT) 治疗.
- 需要进一步调查停止BoNT治疗的原因.
- 优化患者护理需要更深入地了解BoNT治疗在现实环境中的持久性.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.3K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.3K
Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.7K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
Classification of Skeletal Muscle Relaxants
3.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K
Skeletal Muscle Relaxants: Adverse Effects
997
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
997
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.1K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.1K


